NDC 82009-109 – Emtricitabine and Tenofovir Disoproxil Fumarate

Emtricitabine 200 mg/1; Tenofovir Disoproxil Fumarate 300 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC82009-109

Product details

Brand name
Emtricitabine and Tenofovir Disoproxil Fumarate
Generic name
Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
QUALLENT PHARMACEUTICALS HEALTH LLC
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA090513
Marketed since
September 1, 2023
Listing expires
December 31, 2026
Pharmacologic class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emtricitabine and tenofovir disoproxil fumarate →

Package NDC codes (1)

Package NDCDescriptionSince
82009-109-3030 TABLET, FILM COATED in 1 BOTTLE (82009-109-30)Sep 1, 2023

Other Emtricitabine and tenofovir disoproxil fumarate products